Le Lézard
Classified in: Health
Subject: SCZ

Worldshine Adult Medical Day Care Is Now Open In Frederick, Maryland


Looking for somewhere to receive professional nursing services, enjoy a home cooked meal, or shoot some pool?

FREDERICK, Md., Oct. 20, 2022 /PRNewswire-PRWeb/ -- Worldshine is a senior care management company with a passion for enhancing seniors' lifestyles through continuous innovations in care. We strive to provide high quality individualized services and specialty care for the elderly dealing with disabilities and dementia.

Our goal is to help you/your family member extend your independence as long as possible. To attend a day care center is the most affordable way to aging in place. Worldshine Adult Medical Day care is the best and most affordable solution than residential or in-home care services for seniors.

Worldshine AMDC provides medical day care services to seniors who need assistance with activities of daily life (ADLs). At our center, we provide the nursing service, breakfast and lunch, transportation pick up & drop off, activities, social work services.

So, visit us for an open house. Give us a call at 240.422.7166. Visit us at http://www.worldshinecare.com. Let's make the world shine together!

Media Contact

Fatima Knight, Worldshine Adult Medical Day Care, 301.378.2950, [email protected]

 

SOURCE Worldshine Adult Medical Day Care


These press releases may also interest you

at 04:09
Innovation showcase displays growing influence
A news report from China Daily: The 2024 ZGC Forum in Beijing showcased a wide range of latest technological innovations. The event ran from April 25 to 29 and comprised 128 activities, including forums and conferences, technology exchanges,...

at 04:05
U.S. Commercialization Agreement with Quallent to Drive Patient Savings with First High-Concentration Citrate-Free Interchangeable Biosimilar to Humira® (adalimumab)
Alvotech , a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. , disclosed today that under the...

at 03:38
MEDIVIR AB - INTERIM REPORT JANUARY - MARCH 2024
Preparations for the planned phase 2b study continue according to plan after the completed Type C meeting with the FDA, strengthened by the fact that the median time to progression with fostrox + Lenvima increased to 7 months. January ? March...

at 03:05
EAACI Congress 2024: Innovation and Advances in Allergy Treatment
The European Academy of Allergy and Clinical...

at 03:00
BioWorld by Clarivate Explores the Future of CAR T Therapy in Mainland China in Special Report
BioWorldtm published by  Clarivate Plc , a leading global provider of transformative intelligence, explores the growing investment in CAR T therapy development in mainland China in a new series titled "China's CAR T market comes of age." The report...

at 03:00
SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab
SynOx Therapeutics Limited ("SynOx" or the "Company"), the late-stage clinical biopharmaceutical company developing emactuzumab...

More news about Health...


News published on and distributed by: